Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology

Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis

(2015) Chris Stinton et al.   AMERICAN JOURNAL OF PSYCHIATRY

Amyloid imaging for dementia in clinical practice

(2015) John T. O’Brien et al.   BMC Medicine

Quantitative Review Finds No Evidence of Cognitive Effects in Healthy Populations From Single-session Transcranial Direct Current Stimulation (tDCS)

(2015) Jared Cooney Horvath et al.   Brain Stimulation

The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the ‘Oldest Old’: A Systematic Review of the Literature

(2015) Karen Cardwell et al.   DRUGS & AGING

EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

(2015) R. Schmidt et al.   EUROPEAN JOURNAL OF NEUROLOGY

Prevalence of Amyloid PET Positivity in Dementia Syndromes

(2015) Rik Ossenkoppele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

(2015) Tiia Ngandu et al.   LANCET

Vascular dementia

(2015) John T O'Brien et al.   LANCET

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses

(2015) Robert Howard et al.   LANCET NEUROLOGY

Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial

(2015)   LANCET NEUROLOGY

Neuroinflammation in Alzheimer's disease

(2015) Michael T Heneka et al.   LANCET NEUROLOGY

Advances in the treatment of cognitive impairment in Parkinson's disease

(2015) Jennifer G. Goldman et al.   MOVEMENT DISORDERS

Effects of noninvasive brain stimulation on cognitive function in healthy aging and Alzheimer's disease: a systematic review and meta-analysis

(2015) Wan-Yu Hsu et al.   NEUROBIOLOGY OF AGING

Souvenaid Reduces Behavioral Deficits and Improves Social Cognition Skills in Frontotemporal Dementia: A Proof-of-Concept Study

(2015) Matteo Pardini et al.   Neurodegenerative Diseases

Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial

(2015) J. Butchart et al.   NEUROLOGY

Efficacy ofGinkgo bilobaextract EGb 761®in dementia with behavioural and psychological symptoms: A systematic review

(2015) Armin von Gunten et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial

(2015) Manabu Ikeda et al.   Alzheimers Research & Therapy

Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial

(2015) Etsuro Mori et al.   Alzheimers Research & Therapy

Comprehensive treatment of dementia with Lewy bodies

(2015) Brendon P Boot   Alzheimers Research & Therapy

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review

(2015) Mohammed Saji Salahudeen et al.   BMC Geriatrics

Cumulative Use of Strong Anticholinergics and Incident Dementia

(2015) Shelly L. Gray et al.   JAMA Internal Medicine

Diagnostic Accuracy of 123I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study

(2015) Mitsuhiro Yoshita et al.   PLoS One

Diagnostic Criteria for Vascular Cognitive Disorders

(2014) Perminder Sachdev et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Understanding the challenges to implementing case management for people with dementia in primary care in England: a qualitative study using Normalization Process Theory

(2014) Claire Bamford et al.   BMC HEALTH SERVICES RESEARCH

Pathology in Primary Progressive Aphasia Syndromes

(2014) Jennifer M. Harris et al.   Current Neurology and Neuroscience Reports

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

(2014) L. S. Schneider et al.   JOURNAL OF INTERNAL MEDICINE

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

(2014) H.-F. Wang et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias

(2014) J. T. O'Brien et al.   JOURNAL OF NUCLEAR MEDICINE

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

(2014) Adam L Boxer et al.   LANCET NEUROLOGY

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial

(2014) Stéphane Haïk et al.   LANCET NEUROLOGY

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Is it time to revisit the classification guidelines for primary progressive aphasia?

(2014) M.- M. Mesulam et al.   NEUROLOGY

Oxytocin for frontotemporal dementia: A randomized dose-finding study of safety and tolerability

(2014) E. C. Finger et al.   NEUROLOGY

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

(2014) Stephen Salloway et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias?

(2014) Greg J Elder et al.   Alzheimers Research & Therapy

Diagnostic rates and treatment of dementia before and after launch of a national dementia policy: an observational study using English national databases

(2014) Naaheed Mukadam et al.   BMJ Open

Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials

(2014) Serge Gauthier et al.   Clinical Interventions in Aging

Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)

(2013)   Alzheimers & Dementia

Effects of a Non-focal Plasticity Protocol on Apathy in Moderate Alzheimer's Disease: A Randomized, Double-blind, Sham-controlled Trial

(2013) Claudia Kimie Suemoto et al.   Brain Stimulation

Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial

(2013) Adam L Boxer et al.   LANCET NEUROLOGY

Therapeutic effects of non-invasive brain stimulation with direct currents (tDCS) in neuropsychiatric diseases

(2013) Min-Fang Kuo et al.   NEUROIMAGE

Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease

(2013) M. D. Geschwind et al.   NEUROLOGY

Cognitive Decline in Older Persons Initiating Anticholinergic Medications

(2013) Raj C. Shah et al.   PLoS One

Tailored educational intervention for primary care to improve the management of dementia: the EVIDEM-ED cluster randomized controlled trial

(2013) Jane Wilcock et al.   Trials

The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease

(2013) Raj C Shah et al.   Alzheimers Research & Therapy

Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on

(2012) P. M. Maki et al.   CLIMACTERIC

Randomized, Double-Blind, Parallel-Group, 48-Week Study for Efficacy and Safety of a Higher-Dose Rivastigmine Patch (15 vs. 10 cm2) in Alzheimer’s Disease

(2012) Jeffrey Cummings et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Pharmacological prevention and treatment of vascular dementia: Approaches and perspectives

(2012) Andrius Baskys et al.   EXPERIMENTAL GERONTOLOGY

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

(2012) Robert Howard et al.   NEW ENGLAND JOURNAL OF MEDICINE

The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease

(2012) Craig W Ritchie et al.   BMJ Open

Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial

(2012) E. J. Meeuwsen et al.   BMJ-British Medical Journal

The impact of anticholinergic burden in Alzheimer's Dementia-the Laser-AD study

(2011) C. Fox et al.   AGE AND AGEING

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Is High Homocysteine Level a Risk Factor for Cognitive Decline in Elderly? A Systematic Review, Meta-Analysis, and Meta-Regression

(2011) Roger C.M. Ho et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Improving end-of-life care for people with dementia

(2011) Elizabeth L. Sampson et al.   BRITISH JOURNAL OF PSYCHIATRY

Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study

(2011) Chris Fox et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Non-invasive brain stimulation to assess and modulate neuroplasticity in Alzheimer's disease

(2011) Paulo Sérgio Boggio et al.   NEUROPSYCHOLOGICAL REHABILITATION

Efficacy and Tolerability of a Once Daily Formulation of Ginkgo biloba Extract EGb 761® in Alzheimer's Disease and Vascular Dementia: Results from a Randomised Controlled Trial

(2011) R. Ihl et al.   PHARMACOPSYCHIATRY

Is There a Risk of Bleeding Associated with StandardizedGinkgo bilobaExtract Therapy? A Systematic Review and Meta-analysis

(2011) Andrea J Kellermann et al.   PHARMACOTHERAPY

Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial

(2010) Philip Scheltens et al.   Alzheimers & Dementia

EFNS guidelines for the diagnosis and management of Alzheimer’s disease

(2010) J. Hort et al.   EUROPEAN JOURNAL OF NEUROLOGY

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

(2010) John T O’Brien et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Revising the definition of Alzheimer's disease: a new lexicon

(2010) Bruno Dubois et al.   LANCET NEUROLOGY

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

(2010) Murat Emre et al.   LANCET NEUROLOGY

Effectiveness of StandardizedGinkgo bilobaExtract on Cognitive Symptoms of Dementia with a Six-Month Treatment: A Bivariate Random Effect Meta-Analysis

(2010) B.-S. Wang et al.   PHARMACOPSYCHIATRY

Effects of Ginkgo biloba in dementia: systematic review and meta-analysis

(2010) Stefan Weinmann et al.   BMC Geriatrics

Current Concepts in Vascular Cognitive Impairment and Pharmacotherapeutic Implications

(2009) Carlos H Rojas-Fernandez et al.   ANNALS OF PHARMACOTHERAPY

Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase Inhibitors

(2009) Sudeep S. Gill et al.   ARCHIVES OF INTERNAL MEDICINE

Choline Acetyltransferase Activity in Vascular Dementia and Stroke

(2009) Sally I. Sharp et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Primary care and dementia: 2. long-term care at home: psychosocial interventions, information provision, carer support and case management

(2009) Louise Robinson et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies

(2009) A J Mitchell   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Vascular Care in Patients with Alzheimer's Disease with Cerebrovascular Lesions—A Randomized Clinical Trial

(2009) Edo Richard et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

(2009) Dag Aarsland et al.   LANCET NEUROLOGY

Different Responses to Rivastigmine in Subcortical Vascular Dementia and Multi-Infarct Dementia

(2008) Rita Moretti et al.   American Journal of Alzheimers Disease and Other Dementias

Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis

(2008) E. J. Burton et al.   BRAIN

Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial

(2008) Rob McCarney et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies

(2008) Sean J. Colloby et al.   INTERNATIONAL PSYCHOGERIATRICS

Ginkgo biloba for Prevention of DementiaA Randomized Controlled Trial

(2008) Steven T. DeKosky   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

(2008) IM Anderson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Integrating Palliative Medicine into the Care of Persons with Advanced Dementia: Identifying Appropriate Medication Use

(2008) Holly M. Holmes et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

(2008) Rachelle S Doody et al.   LANCET

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL

(2008) Martin Dichgans et al.   LANCET NEUROLOGY

A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline

(2008) H. H. Dodge et al.   NEUROLOGY